As with other GLP-1 agonists, prescribers adding dulaglutide to a patient's regimen may need to reduce the dose of concomitant sulfonylurea or insulin, to reduce the risk of hypoglycaemia
This is up to five times the normal energy use than if they had not been removed, which uses up their energy stores unnecessarily
(1985) reported faster intestinal transit time and increased enteroglucagon levels in patients with greater weight loss compared to weight-stable patients
The Difference between GLP-1 Weight Loss Patches & Injections If youre hoping for the results youve heard about with Wegovy or Mounjaro, patches wont deliver the same results
For anyone following this peptide, this is the trial the community has been waiting for
Paruthi J, Gill N, Mantzoros CS: Adipokines in the HIV/HAART-associated lipodystrophy syndrome